Hide This

FREEHER HealthToolkit

HER Health Toolkit

Sign up for EmpowHER updates and you'll receive our
FREE HER Health Toolkit

Urinary Incontinence

Get Email Updates

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!

BOTOX® Approved by FDA for Overactive Bladder Patients

By Jody Smith HERWriter
 
Rate This
BOTOX® Approved by FDA for Overactive Bladder Patients 4 5 2
FDA approves Botox for patients with OAB
Auremar/PhotoSpin

On January 18, 2013, Allergan, Inc. made the announcement that BOTOX® (onabotulinumtoxinA) has been approved by the FDA to treat overactive bladder for adults who cannot tolerate anticholinergic medication, or who do not have an adequate response to such medications.

Scott Whitcup, M.D. is Allergan's Executive Vice President, Research and Development and Chief Scientific Officer. Whitcup said, "We are proud to bring the seventh medical use of BOTOX® in the United States to market. BOTOX® is the first neurotoxin to undergo formal clinical evaluation and receive FDA approval for a urological indication. This approval of BOTOX® is an important milestone in Allergan's commitment to develop and make available novel treatment options for urologists and their patients."

Overactive bladder, or OAB, involves urgent and frequent in urination, as well as urge urinary incontinence. Approximately 33 million American adults live with this condition.

While some with OAB use anticholinergics, more than half of these OAB patients stop taking these medications within a year because it does not adequately control their symptoms, or they cannot tolerate the medication.

Dr. Victor Nitti, Vice-Chairman, Department of Urology, NYU Langone Medical Center, was involved in the BOTOX® Phase III clinical trial program.

Nitti said, "When not adequately managed, urinary incontinence due to detrusor overactivity in patients living with MS (Multiple Sclerosis) or SCI (spinal cord injury) can lead to skin irritation, ulcers, pressure increases in the bladder that can cause kidney failure, as well as recurrent urinary tract infections."

BOTOX® injections in the bladder muscle via cystocopy can relax the bladder, making for greater storage capacity and decreasing the frequency of urinary incontinence. Cystoscopy makes it possible for a doctor to see the inside of the bladder during the injection.

Two clinical trials of 1105 patients with OAB have established the safety and efficacy of BOTOX® when it was administered randomly to patients in injections of 100 units of Botox (20 injections of 5 units each) or placebo.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Improved

1679 Health

Changed

630 Lives

Saved

479 Lives
3 lives impacted in the last 24 hrs Learn More

Take Our Featured Health Poll

Do you suffer from overactive bladder?:
View Results